Evidence map›Paper›PMID 40663134›Full record

ArticleArchives of microbiology2025

Metabolic and fermentation engineering of Klebsiella Pneumoniae for high-level production of 3-hydroxypropionic acid.

Qing-Yi Cao, Hui-Ying Xu, Bang-Ce Ye, Ying Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qing-Yi CaoLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China.
Hui-Ying XuLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China.
Bang-Ce YeLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China. bcye@ecust.edu.cn.
Ying ZhouLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China. zhouying@ecust.edu.cn.ORCID http://orcid.org/0000-0001-9241-1293

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

3-hydroxypropionic acid (3-HP) is an essential C3 platform chemical with considerable potential for synthesizing various chemicals and biodegradable materials. However, efficient production of 3-HP is still an urgent problem. In this study, a comprehensive approach involving the screening and mutation of KGSADH, along with the optimization of ribosome binding sites (RBS), promoters, and the downregulation of competing metabolic pathways, led to a marked improvement in 3-HP production, achieving a concentration of 6.67 g/L in shake flask cultures. Furthermore, innovatively changing inducible promoters to achieve constitutive protein expression. Then replacing yeast extract with corn steep liquor resulted in a notable increase in 3-HP titer, rising from 86.80 to 102.56 g/L. The reduction of residual glycerol concentrations to below 25 g/L further enhanced production, culminating in a final titer of 110.70 g/L, which is the highest titer for 3-HP production in Klebsiella pneumoniae to date. These findings underscore the potential of engineered microbial systems in optimizing the sustainable production of valuable platform chemicals from renewable feedstocks.

Indexed as

Klebsiella pneumoniaeLactic AcidMetabolic EngineeringBacterial ProteinsBioreactorsFermentationGlycerolMetabolic Networks and PathwaysPromoter Regions, GeneticBacterial ProteinsGlycerolhydracrylic acidLactic Acid3-Hydroxypropionic acid5L-bioreactor condition optimizationKGSADHKlebsiella pneumoniaeThe enzyme engineering

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.